Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174989 | SCV000226404 | uncertain significance | not provided | 2017-05-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000397231 | SCV000362830 | likely benign | COFS syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307545 | SCV000362831 | likely benign | Cockayne syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000364521 | SCV000362832 | likely benign | Macular degeneration | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000174989 | SCV001013406 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000174989 | SCV001714946 | uncertain significance | not provided | 2022-11-25 | criteria provided, single submitter | clinical testing | PP3 |
Gene |
RCV000174989 | SCV002072817 | uncertain significance | not provided | 2022-01-14 | criteria provided, single submitter | clinical testing | Alters the last nucleotide of the exon and is predicted to destroy the splice donor site and result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ce |
RCV000174989 | SCV004184047 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | ERCC6: PP3, BS2 |
Diagnostic Laboratory, |
RCV000174989 | SCV001741045 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000174989 | SCV001959095 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000174989 | SCV002038064 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537372 | SCV004751088 | likely benign | ERCC6-related disorder | 2022-10-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |